跳至主要内容
临床试验/JPRN-UMIN000008843
JPRN-UMIN000008843招募中3 期

Efficacy of intermittent versus continuous endocrine therapy on localized and non-palpable prostate cancer: a multi-center randomized controlled trial - Intermittent vs. continuous endocrine therapy for T1cN0M0 prostate cancer : a multi-center randomized controlled trial (INCEL trial)

Chiba Prostate Study Group0 个研究点目标入组 600 人开始时间: 2012年10月1日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 80years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • •<Pre-registration> 1) Active malignancy in other organs 2) Serum testosterone under 100 ng/dL or 1 ng/mL 3) Under continuous oral administration of 5-alpha reductase inhibitor or steroids 4) Diagnosed with osteoporosis and under oral treatment 5) Other reasons for being inadequate case judged by the attending doctor <Registration> While 6-months introduction treatment, 1) escape from criteria of prohibited treatments and drugs 2) intake of bicaltamide less than 50% 3) escape from criteria of amount and intervals of LH-RH agonists

研究者

发起方
Chiba Prostate Study Group

相似试验